These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7859740)

  • 21. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
    Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperative binding of tetrameric p53 to DNA.
    Weinberg RL; Veprintsev DB; Fersht AR
    J Mol Biol; 2004 Aug; 341(5):1145-59. PubMed ID: 15321712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1994 Jul; 265(5170):386-91. PubMed ID: 8023159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.
    Nie Y; Li HH; Bula CM; Liu X
    Mol Cell Biol; 2000 Feb; 20(3):741-8. PubMed ID: 10629029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.
    van Dieck J; Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
    J Biol Chem; 2009 May; 284(20):13804-13811. PubMed ID: 19297317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solution structure of the tetrameric minimum transforming domain of p53.
    Lee W; Harvey TS; Yin Y; Yau P; Litchfield D; Arrowsmith CH
    Nat Struct Biol; 1994 Dec; 1(12):877-90. PubMed ID: 7773777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA.
    Klein C; Planker E; Diercks T; Kessler H; Künkele KP; Lang K; Hansen S; Schwaiger M
    J Biol Chem; 2001 Dec; 276(52):49020-7. PubMed ID: 11606582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.
    Poon GM; Brokx RD; Sung M; Gariépy J
    J Mol Biol; 2007 Jan; 365(4):1217-31. PubMed ID: 17113101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants.
    Waterman MJ; Waterman JL; Halazonetis TD
    Cancer Res; 1996 Jan; 56(1):158-63. PubMed ID: 8548757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.
    McCoy M; Stavridi ES; Waterman JL; Wieczorek AM; Opella SJ; Halazonetis TD
    EMBO J; 1997 Oct; 16(20):6230-6. PubMed ID: 9321402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Foord OS; Bhattacharya P; Reich Z; Rotter V
    Nucleic Acids Res; 1991 Oct; 19(19):5191-8. PubMed ID: 1923804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of DNA binding of p53 by its C-terminal domain.
    Weinberg RL; Freund SM; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2004 Sep; 342(3):801-11. PubMed ID: 15342238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution.
    Sakamoto H; Lewis MS; Kodama H; Appella E; Sakaguchi K
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8974-8. PubMed ID: 8090755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.